Literature DB >> 32311549

Surgical Treatment and Predictive Factors for Atypical Meningiomas: A Multicentric Experience.

Mauro Dobran1, Alessandra Marini2, Bruno Splavski3, Kresimir Rotim3, Valentina Liverotti2, Davide Nasi2, Maurizio Iacoangeli2.   

Abstract

BACKGROUND: Atypical meningiomas are characterized by a high rate of recurrence and shorter overall survival (OS) compared with grade I meningioma. Predictive parameters for OS and recurrence-free survival (RFS) are controversial.
METHODS: Patient age, sex, preoperative symptoms, tumor localization, size, Simpson grade, postoperative complications, extent of resection, number of mitoses, MIB1 proliferation index, brain invasion, postoperative radiotherapy, and clinical outcome (Karnofsky performance scale [KPS] postoperatively and at long-term follow-up) were evaluated. Data regarding recurrence rate, mortality, OS, and RFS at 1-, 3-, and 5-year follow-up were also collected. Median follow-up was 76 months; all patients had at least 3 years of follow-up.
RESULTS: Between 2007 and 2017, 73 patients underwent surgery for atypical meningiomas (World Health Organization grade II) at 2 centers. Preoperative KPS score >80 as well as 1-month, 6-month, and 1-year follow-up KPS scores were related to better OS. Postoperative complications did not modify OS and RFS. Gross total removal (Simpson grade I, II) was achieved in 80.8% of patients. RFS was statistically influenced by extent of resection (P = 0.002). MIB1 proliferation index >8 was a negative predictive factor for recurrence at univariate and multivariate analysis (P = 0.001 and P = 0.021). Radiotherapy was statistically related to a worse outcome. The incidence of recurrence was 38%. RFS was 98.6% at 1-year follow-up, 81.1% at 3 years, and 57.5% at 5 years. All patients were alive at 1-year follow-up. OS was 90.5% at 3-year follow-up and 78.8% at 5-year follow-up.
CONCLUSIONS: Despite some limitations, our study demonstrates that aggressive surgical treatment achieving a gross total removal is a positive predictive parameter for RFS as well as a good clinical outcome (KPS score >80) and is related to a longer OS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical meningioma; Grade II meningiomas; Overall survival; Progression-free survival; Tumor recurrence

Mesh:

Year:  2020        PMID: 32311549     DOI: 10.1016/j.wneu.2020.03.201

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Expression of GLUT3 and HIF-1α in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.

Authors:  Tao Mei; Zhengjun Wang; Jianwu Wu; Xianhua Liu; Wei Tao; Shousen Wang; Fuyong Chen
Journal:  Biomed Res Int       Date:  2020-08-29       Impact factor: 3.411

2.  Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology.

Authors:  Roel H L Haeren; Ilari Rautalin; Christoph Schwartz; Miikka Korja; Mika Niemelä
Journal:  J Neurooncol       Date:  2021-01-21       Impact factor: 4.130

3.  Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma.

Authors:  Xiao-Yong Chen; Jin-Yuan Chen; Yin-Xing Huang; Jia-Heng Xu; Wei-Wei Sun; Yue- Chen; Chen-Yu Ding; Shuo-Bin Wang; Xi-Yue Wu; De-Zhi Kang; Hong-Hai You; Yuan-Xiang Lin
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.